Cordlife Group Limited

Company in the news

Parental fury after Cordlife ruins thousands of samples in Singapore

The company has “little regard and no remorse for losing something so precious,” said one parent, who was offered about $5,000.

Company in the news

Cordlife receives interim injunction against latest private placement

In its statement dated April 22, Cordlife says that is currently seeking legal advice.

Company in the news

CAD arrests Cordlife’s CFO in connection with potential breaches of disclosure obligations

Thet Hnin Yi will still remain in her position as CFO, says the company.

Insider moves

Cordlife’s substantial shareholder sells 4.6 mil shares in off-market transaction

Following the sale, Robust Plan, which formerly held a 5.47% stake in Cordlife, now owns a 3.67% stake in the latter.

Company in the news

Cordlife accepts suspension from MOH to stop collecting new cord blood and human tissues for six months

The company says it is not able to assess the financial impact of the investigation on the group’s performance for the FY2023.

Broker's Calls

Broker's Digest: Del Monte, Cordlife, ComfortDelGro, Megachem, Rex International

See what the analysts have to say on these counters.

Broker's Calls

Cordlife deemed as 'interesting target to be privatised': Soochow CSSD Capital Markets

The brokerage has kept "buy" on the counter with an unchanged target price of 47 cents.
Cordlife launches first-of-its-kind corneal lenticule banking service in Singapore - THE EDGE SINGAPORE

Healthcare

Cordlife launches first-of-its-kind corneal lenticule banking service in Singapore

This makes it the first company in Asia to offer such a service.

Results

Cordlife sees 3Q losses narrow 80.4% to $0.4 mil

SINGAPORE (May 12): Cordlife Holdings says 3Q17 losses narrowed to $0.4 million from $2 million a year ago.
×